Literature DB >> 17145341

Steroid receptors and their role in the biology and control of breast cancer growth.

Fernando Cordera1, V Craig Jordan.   

Abstract

Steroid hormone receptors (estrogen receptor [ER] and progesterone receptor [PR]) play a critical role in the development of breast cancer. Most importantly, the expression of ER and/or PR by tumor cells provides important information that is critical for the selection of treatment. Recent studies on ER and PR have provided new insights into the pathogenesis of breast cancer and the mechanisms of resistance to antihormonal therapy. Better understanding of steroid receptors, their ligands, and the mechanisms through which they exert their effects will allow the correct treatment to be targeted to responsive tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145341     DOI: 10.1053/j.seminoncol.2006.08.020

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  28 in total

Review 1.  What have we learned about GPER function in physiology and disease from knockout mice?

Authors:  Eric R Prossnitz; Helen J Hathaway
Journal:  J Steroid Biochem Mol Biol       Date:  2015-07-16       Impact factor: 4.292

2.  Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17β-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells.

Authors:  Yan Chen; Duan-Yang Hong; Jing Wang; Jun Ling-Hu; Yan-Yan Zhang; Di Pan; Yi-Ni Xu; Ling Tao; Hong Luo; Xiang-Chun Shen
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

3.  Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

5.  Revisiting estrogen: efficacy and safety for postmenopausal bone health.

Authors:  Sandra M Sacco; Wendy E Ward
Journal:  J Osteoporos       Date:  2010-06-22

6.  Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.

Authors:  Shyam N Sundar; Crystal N Marconett; Victor B Doan; Jamin A Willoughby; Gary L Firestone
Journal:  Carcinogenesis       Date:  2008-09-10       Impact factor: 4.944

Review 7.  Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.

Authors:  Grazia Arpino; Lisa Wiechmann; C Kent Osborne; Rachel Schiff
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

8.  Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.

Authors:  Charlton Cooper; Jimin Guo; Yi Yan; Shilpa Chooniedass-Kothari; Florent Hube; Mohammad K Hamedani; Leigh C Murphy; Yvonne Myal; Etienne Leygue
Journal:  Nucleic Acids Res       Date:  2009-05-29       Impact factor: 16.971

9.  Keratin 18 attenuates estrogen receptor alpha-mediated signaling by sequestering LRP16 in cytoplasm.

Authors:  Yuanguang Meng; Zhiqiang Wu; Xiaoyun Yin; Yali Zhao; Meixia Chen; Yiling Si; Jie Yang; Xiaobing Fu; Weidong Han
Journal:  BMC Cell Biol       Date:  2009-12-26       Impact factor: 4.241

10.  Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.

Authors:  Yue Sun; Dmitry A Turbin; Kun Ling; Narendra Thapa; Samuel Leung; David G Huntsman; Richard A Anderson
Journal:  Breast Cancer Res       Date:  2010-01-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.